BRIEF-CBC Group Says Hasten Biopharmaceutical Acquires 14 Celltrion Legacy Products
July 1 (Reuters) - CBC Group:
* CBC-BACKED HASTEN BIOPHARMACEUTICAL ANNOUNCES ACQUISITION OF 14 CELLTRION LEGACY PRODUCTS
* UNDER AGREEMENT, HASTEN WILL OWN MARKETING AUTHORIZATION HOLDER RIGHTS FOR 14 PRODUCTS IN 8 COUNTRIES & REGIONS, INCLUDING SOUTH KOREA